NCT03836677View on ClinicalTrials.gov

A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

November 11, 2019

Study Completion Date

November 11, 2019

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
COMBINATION_PRODUCT

BGF

Treatment with Budesonide/Glycopyrronium/FormoterolFumarate

COMBINATION_PRODUCT

GFF

Treatment with Glycopyrronium/Formoterol Fumarate

Trial Locations (4)

5101

Research Site, Erpent

5623 EJ

Research Site, Eindhoven

9713 GZ

Research Site, Groningen

7207 AE

Research Site, Zutphen

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY